256 related articles for article (PubMed ID: 14552419)
21. Formation of lactones from sialylated MUC1 glycopeptides.
Pudelko M; Lindgren A; Tengel T; Reis CA; Elofsson M; Kihlberg J
Org Biomol Chem; 2006 Feb; 4(4):713-20. PubMed ID: 16467946
[TBL] [Abstract][Full Text] [Related]
22. The development of synthetic antitumour vaccines from mucin glycopeptide antigens.
Gaidzik N; Westerlind U; Kunz H
Chem Soc Rev; 2013 May; 42(10):4421-42. PubMed ID: 23440054
[TBL] [Abstract][Full Text] [Related]
23. Synthetic multivalent glycopeptide-lipopeptide antitumor vaccines: impact of the cluster effect on the killing of tumor cells.
Cai H; Sun ZY; Chen MS; Zhao YF; Kunz H; Li YM
Angew Chem Int Ed Engl; 2014 Feb; 53(6):1699-703. PubMed ID: 24449389
[TBL] [Abstract][Full Text] [Related]
24. Nuclear magnetic resonance-based dissection of a glycosyltransferase specificity for the mucin MUC1 tandem repeat.
Brokx RD; Revers L; Zhang Q; Yang S; Mal TK; Ikura M; Gariépy J
Biochemistry; 2003 Dec; 42(47):13817-25. PubMed ID: 14636048
[TBL] [Abstract][Full Text] [Related]
25. Glycopeptide and glycoprotein synthesis involving unprotected carbohydrate building blocks.
Guo Z; Shao N
Med Res Rev; 2005 Nov; 25(6):655-78. PubMed ID: 15895471
[TBL] [Abstract][Full Text] [Related]
26. Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen.
Marcos NT; Pinho S; Grandela C; Cruz A; Samyn-Petit B; Harduin-Lepers A; Almeida R; Silva F; Morais V; Costa J; Kihlberg J; Clausen H; Reis CA
Cancer Res; 2004 Oct; 64(19):7050-7. PubMed ID: 15466199
[TBL] [Abstract][Full Text] [Related]
27. A totally synthetic, self-assembling, adjuvant-free MUC1 glycopeptide vaccine for cancer therapy.
Huang ZH; Shi L; Ma JW; Sun ZY; Cai H; Chen YX; Zhao YF; Li YM
J Am Chem Soc; 2012 May; 134(21):8730-3. PubMed ID: 22587010
[TBL] [Abstract][Full Text] [Related]
28. Solid-phase synthesis of the glycopeptide of human glycophorin AM bearing the consecutive sialyl-T antigen.
Ando S; Nakahara Y; Ito Y; Ogawa T; Nakahara Y
Carbohydr Res; 2000 Dec; 329(4):773-80. PubMed ID: 11125819
[TBL] [Abstract][Full Text] [Related]
29. Preparation of glycosylated amino acids suitable for Fmoc solid-phase assembly.
Cudic M; Burstein GD
Methods Mol Biol; 2008; 494():187-208. PubMed ID: 18726575
[TBL] [Abstract][Full Text] [Related]
30. Convergent total synthesis of a tumour-associated mucin motif.
Sames D; Chen XT; Danishefsky SJ
Nature; 1997 Oct; 389(6651):587-91. PubMed ID: 9335496
[TBL] [Abstract][Full Text] [Related]
31. Fluorinated glycosyl amino acids for mucin-like glycopeptide antigen analogues.
Wagner S; Mersch C; Hoffmann-Röder A
Chemistry; 2010 Jun; 16(24):7319-30. PubMed ID: 20461825
[TBL] [Abstract][Full Text] [Related]
32. Chemoenzymatic synthesis of a MUC1 glycopeptide carrying non-natural sialyl TF-beta O-glycan.
Tanaka E; Nakahara Y; Kuroda Y; Takano Y; Kojima N; Hojo H; Nakahara Y
Biosci Biotechnol Biochem; 2006 Oct; 70(10):2515-22. PubMed ID: 17031043
[TBL] [Abstract][Full Text] [Related]
33. Lack of polymorphism in MUC1 tandem repeats in cancer cells is related to breast cancer progression in Japanese women.
Kawaguchi T; Takazawa H; Imai S; Morimoto J; Watanabe T
Breast Cancer Res Treat; 2005 Aug; 92(3):223-30. PubMed ID: 16155793
[TBL] [Abstract][Full Text] [Related]
34. T cells recognize PD(N/T)R motif common in a variable number of tandem repeat and degenerate repeat sequences of MUC1.
Pisarev VM; Kinarsky L; Caffrey T; Hanisch FG; Sanderson S; Hollingsworth MA; Sherman S
Int Immunopharmacol; 2005 Feb; 5(2):315-30. PubMed ID: 15652762
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and immunological evaluation of self-assembling and self-adjuvanting tricomponent glycopeptide cancer-vaccine candidates.
Wilkinson BL; Day S; Chapman R; Perrier S; Apostolopoulos V; Payne RJ
Chemistry; 2012 Dec; 18(51):16540-8. PubMed ID: 23090901
[TBL] [Abstract][Full Text] [Related]
36. Parallel solid-phase synthesis of mucin-like glycopeptides.
Liu M; Barany G; Live D
Carbohydr Res; 2005 Sep; 340(13):2111-22. PubMed ID: 16026772
[TBL] [Abstract][Full Text] [Related]
37. Solution-phase synthesis with solid-state workup of an O-glycopeptide with a cluster of cancer-related T antigens.
Shao N; Guo Z
Org Lett; 2005 Aug; 7(16):3589-92. PubMed ID: 16048349
[TBL] [Abstract][Full Text] [Related]
38. Conformational consequences of protein glycosylation: preparation of O-mannosyl serine and threonine building blocks, and their incorporation into glycopeptide sequences derived from alpha-dystroglycan.
Liu M; Borgert A; Barany G; Live D
Biopolymers; 2008; 90(3):358-68. PubMed ID: 17868094
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and Immunological Evaluation of Disaccharide Bearing MUC-1 Glycopeptide Conjugates with Virus-like Particles.
Wu X; McKay C; Pett C; Yu J; Schorlemer M; Ramadan S; Lang S; Behren S; Westerlind U; Finn MG; Huang X
ACS Chem Biol; 2019 Oct; 14(10):2176-2184. PubMed ID: 31498587
[TBL] [Abstract][Full Text] [Related]
40. Molecular basis of incomplete O-glycan synthesis in MCF-7 breast cancer cells: putative role of MUC6 in Tn antigen expression.
Freire T; Bay S; von Mensdorff-Pouilly S; Osinaga E
Cancer Res; 2005 Sep; 65(17):7880-7. PubMed ID: 16140958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
